絕味食品(603517.SH)澄清:研發費用存在差異系列報口徑差異所致
格隆匯11月30日丨絕味食品(603517.SH)公告稱,近日,公司關注到有媒體在網絡上發佈題為《研發費用自相矛盾,4500萬不易而飛,靠一根鴨脖撐起市值500億的“鴨脖之王”被高估了嗎?》的文章。公司第一時間關注到上述報道並立即展開了認真核實,為了避免對投資者造成誤導,現予以澄清説明。
2017年披露的公司年報“經營成果分析”章節中的研發投入-研發費用投入與2018年財務報表列報的上期研發費用存在差異系公司產研結合下生產研發模式下業務口徑對於研發費用投入的理解與2018年6月財政部規定的財務報表列報的研發費用存在口徑差異。
2018年,財政部公佈了《關於修訂印發2018年度一般企業財務報表格式的通知》(財會〔2018〕15號)文件後,公司業務口徑與財務口徑進行了統一,年報“經營成果分析”章節中的研發投入—研發費用投入與財務報表—研發費用金額一致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.